These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8680402)

  • 1. Applications of heteroduplex analysis for mutation detection in disease genes.
    Glavac D; Dean M
    Hum Mutat; 1995; 6(4):281-7. PubMed ID: 8680402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the commonest cystic fibrosis transmembrane regulator gene DeltaF508 mutation: evaluation of PCR--single-strand conformational polymorphism and polyacrylamide gel electrophoresis.
    Kakavas KV; Noulas AV; Kanakis I; Bonanou S; Karamanos NK
    Biomed Chromatogr; 2006 Oct; 20(10):1120-5. PubMed ID: 16708396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel.
    Zielenski J; Aznarez I; Onay T; Tzounzouris J; Markiewicz D; Tsui LC
    Methods Mol Med; 2002; 70():3-19. PubMed ID: 11917532
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutation detection by denaturing DNA chromatography using fluorescently labeled polymerase chain reaction products.
    Hecker KH; Taylor PD; Gjerde DT
    Anal Biochem; 1999 Aug; 272(2):156-64. PubMed ID: 10415084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection.
    Nataraj AJ; Olivos-Glander I; Kusukawa N; Highsmith WE
    Electrophoresis; 1999 Jun; 20(6):1177-85. PubMed ID: 10380757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of heteroduplex and single-strand conformation analyses, followed by ethidium fluorescence visualization, for the detection of mutations in four human genes.
    Rossetti S; Corrà S; Biasi MO; Turco AE; Pignatti PF
    Mol Cell Probes; 1995 Jun; 9(3):195-200. PubMed ID: 7477013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis mutation frequencies in upstate New York.
    Shrimpton AE; Borowitz D; Swender P
    Hum Mutat; 1997; 10(6):436-42. PubMed ID: 9401006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSCP analysis: a blind sensitivity trial.
    Jordanova A; Kalaydjieva L; Savov A; Claustres M; Schwarz M; Estivill X; Angelicheva D; Haworth A; Casals T; Kremensky I
    Hum Mutat; 1997; 10(1):65-70. PubMed ID: 9222762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosensor technology for real-time detection of the cystic fibrosis W1282X mutation in CFTR.
    Feriotto G; Ferlini A; Ravani A; Calzolari E; Mischiati C; Bianchi N; Gambari R
    Hum Mutat; 2001; 18(1):70-81. PubMed ID: 11438995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of exon 1 NRAS gene mutations using universal heteroduplex generator technology.
    Belli C; De Brasi C; Larripa I
    Hum Mutat; 2003 Feb; 21(2):132-7. PubMed ID: 12552560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
    Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
    Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD).
    Edwards SM; Kote-Jarai Z; Hamoudi R; Eeles RA
    Hum Mutat; 2001 Mar; 17(3):220-32. PubMed ID: 11241844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
    Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
    Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct genomic multiplex PCR for BRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis.
    Barker DF
    Hum Mutat; 2000 Oct; 16(4):334-44. PubMed ID: 11013444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSCP/heteroduplex analysis.
    Wallace AJ
    Methods Mol Biol; 2002; 187():151-63. PubMed ID: 12013742
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
    D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
    BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
    Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
    Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic screening and testing by induced heteroduplex formation.
    Wood N; Bidwell J
    Electrophoresis; 1996 Jan; 17(1):247-54. PubMed ID: 8907549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.